LOTRISONE Drug Patent Profile
✉ Email this page to a colleague
When do Lotrisone patents expire, and what generic alternatives are available?
Lotrisone is a drug marketed by Organon and Merck Sharp Dohme and is included in two NDAs.
The generic ingredient in LOTRISONE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOTRISONE?
- What are the global sales for LOTRISONE?
- What is Average Wholesale Price for LOTRISONE?
Summary for LOTRISONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LOTRISONE |
| What excipients (inactive ingredients) are in LOTRISONE? | LOTRISONE excipients list |
| DailyMed Link: | LOTRISONE at DailyMed |
Recent Clinical Trials for LOTRISONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jilin University | Phase 2 |
US Patents and Regulatory Information for LOTRISONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | LOTRISONE | betamethasone dipropionate; clotrimazole | LOTION;TOPICAL | 020010-001 | Dec 8, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOTRISONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Organon | LOTRISONE | betamethasone dipropionate; clotrimazole | CREAM;TOPICAL | 018827-001 | Jul 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOTRISONE
See the table below for patents covering LOTRISONE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 358531 | ⤷ Sign Up | |
| France | 8112 | ⤷ Sign Up | |
| Norway | 124110 | ⤷ Sign Up | |
| Yugoslavia | 215168 | ⤷ Sign Up | |
| New Zealand | 198559 | PHARMACEUTICAL COMPOSITIONS CONTAINING BETAMETHASONE DIPROPIONATE AND CLOTRIMAZOLE | ⤷ Sign Up |
| Sweden | 341633 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
